3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
SCLC
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
High Grade Serous Carcinoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Malignancies
1
Adenocarcinoma
1
Interventions
Carboplatin
49
Etoposide
46
Cisplatin
42
Topotecan
39
Irinotecan
21
Paclitaxel
20
Nivolumab
15
pembrolizumab
13
Gemcitabine
13
atezolizumab
11
Ipilimumab
11
durvalumab
9
Radiotherapy
9
Doxorubicin
7
Bevacizumab
7
rovalpituzumab tesirine
6
etoposide phosphate
6
amrubicin
6
Psychiatric Rehabilitation
6
PM 01183
6
Docetaxel
6
Counseling
6
trilaciclib
5
Temozolomide
5
Sunitinib
5
Platinum
5
Imatinib Mesylate
5
Cyclophosphamide
5
Bortezomib
5
130-nm albumin-bound paclitaxel
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Small Cell Lung Carcinoma
×
ceralasertib
×
Clear all
NCT04361825
2024-01-03
SUKSES-N4
Samsung Medical Center
Phase 2
Completed
42 enrolled